Zobrazeno 1 - 10
of 155
pro vyhledávání: '"Veronica, Miller"'
Autor:
Robin Schaefer, Alessi Ayvaz, Christopher R. Hoffman, Margot Yann, Zachary Rooney, Mitchell Leus, Shilpa Mitra, Veronica Miller, for the Forum for Collaborative Research
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 10, Pp n/a-n/a (2024)
Abstract Developing safe and effective drugs and other medical products is a complex and costly process. Drug development has been, historically, commonly competitive and uncollaborative, and this tendency toward a lack of interaction between stakeho
Externí odkaz:
https://doaj.org/article/1bc5c83929be49959c882d4b06c80538
Publikováno v:
Journal of Virus Eradication, Vol 10, Iss 2, Pp 100376- (2024)
Externí odkaz:
https://doaj.org/article/8b82ffe418054b3a87bacc646d58c437
Publikováno v:
Journal of the International AIDS Society, Vol 26, Iss S2, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/99c45eb01a5c4d798646f7379aed700d
Autor:
Nombuyiselo Mofokeng, Tongai G. Maponga, Marije van Schalkwyk, Susan Hugo, Molefi Daniel Morobadi, Sabeehah Vawda, Leane Badenhorst, Cloete van Vuuren, Christo van Rensburg, Wolfgang Preiser, Jantjie Taljaard, Su Wang, Veronica Miller, Dan Wu, Joseph D. Tucker, Janet Seeley, Dominique Goedhals, Philippa C. Matthews
Publikováno v:
Journal of Virus Eradication, Vol 9, Iss 1, Pp 100317- (2023)
High profile international goals have been set for the elimination of hepatitis B virus (HBV) infection as a public health threat by the year 2030. Developing and expanding equitable, accessible translational HBV research programmes that represent re
Externí odkaz:
https://doaj.org/article/a5d33dad03d4413f9ccc671a988b9287
Autor:
Kelley M. Kidwell, Satrajit Roychoudhury, Barbara Wendelberger, John Scott, Tara Moroz, Shaoming Yin, Madhurima Majumder, John Zhong, Raymond A. Huml, Veronica Miller
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-15 (2022)
Abstract Background Design and analysis of clinical trials for rare and ultra-rare disease pose unique challenges to the practitioners. Meeting conventional power requirements is infeasible for diseases where sample sizes are inherently very small. M
Externí odkaz:
https://doaj.org/article/84cee3bd18ce4f7ab0c594ae52873f16
Autor:
Joseph Kin-On Lau, Nicholas Murdock, Jeffrey Murray, Jessica Justman, Neil Parkin, Veronica Miller
Publikováno v:
Journal of Virus Eradication, Vol 8, Iss 3, Pp 100085- (2022)
Introduction: The need for detection of new and recent HIV infections is essential for surveillance and assessing interventions in controlling the epidemic. HIV recency assays are one way of providing reliable incidence estimates by determining recen
Externí odkaz:
https://doaj.org/article/ffd247d3215e4566b3d8c0ce647c6355
Autor:
Elizabeth Clearfield, Veronica Miller, Joseph Nadglowski, Katherine Barradas, Jennifer Al Naber, Arun J. Sanyal, Brent A. Neuschwander‐Tetri, Donna A. Messner, the coreNASH Panel
Publikováno v:
Hepatology Communications, Vol 5, Iss 5, Pp 774-785 (2021)
The increasing prevalence and burden of nonalcoholic steatohepatitis (NASH) has spurred the development of new treatments and a need to consider outcomes used for NASH treatment decision making. Development of a NASH core outcome set (COS) can help p
Externí odkaz:
https://doaj.org/article/63820c4e29ad4c09b5ddea4cab18df80
Autor:
Tinkhani Mbichila, Grace Kumwenda, Ntando Yola, Quarraisha Abdool Karim, Tamar Tchelidze, Joseph Lau, Stephanie Buchholz, Regine Lehnert, Jean-Michel Molina, Kenneth Mayer, Veronica Miller
Publikováno v:
Journal of Virus Eradication, Vol 7, Iss 1, Pp 100030- (2021)
Externí odkaz:
https://doaj.org/article/1b91d9d4dff8404f8b8f9088854571e3
Autor:
Elena Ivanova Reipold, Philippa Easterbrook, Alessandra Trianni, Nivedha Panneer, Douglas Krakower, Stefano Ongarello, Teri Roberts, Veronica Miller, Claudia Denkinger
Publikováno v:
BMC Infectious Diseases, Vol 17, Iss S1, Pp 159-175 (2017)
Abstract Background The current low access to virological testing to confirm chronic viraemic HCV infection in low- and middle-income countries (LMIC) is limiting the rollout of hepatitis C (HCV) care. Existing tests are complex, costly and require s
Externí odkaz:
https://doaj.org/article/487cfa76c83447308580245d0decdd36
Autor:
Joseph D. Tucker, Kathrine Meyers, John Best, Karyn Kaplan, Razia Pendse, Kevin A. Fenton, Isabelle Andrieux-Meyer, Carmen Figueroa, Pedro Goicochea, Charles Gore, Azumi Ishizaki, Giten Khwairakpam, Veronica Miller, Antons Mozalevskis, Michael Ninburg, Ponsiano Ocama, Rosanna Peeling, Nick Walsh, Massimo G. Colombo, Philippa Easterbrook
Publikováno v:
BMC Infectious Diseases, Vol 17, Iss S1, Pp 177-185 (2017)
Abstract Background Innovation contests are a novel approach to elicit good ideas and innovative practices in various areas of public health. There remains limited published literature on approaches to deliver hepatitis testing. The purpose of this i
Externí odkaz:
https://doaj.org/article/c84a0fb8bf1948979e8a707ff42a82d1